{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:14:03Z","timestamp":1790248443795,"version":"4.1.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>\n                    <jats:italic>Achromobacter<\/jats:italic>\n                    spp. are aerobic, non-fermentative, Gram-negative opportunistic pathogens belonging to the family Alcaligenaceae, order\n                    <jats:italic>Burkholderiales<\/jats:italic>\n                    , and are widely distributed in natural environments such as soil and water. In patients with cystic fibrosis (CF),\n                    <jats:italic>Achromobacter<\/jats:italic>\n                    spp. have emerged as increasingly prevalent opportunistic pathogens, with detection rates in respiratory samples rising from approximately 2\u20133% in the 1990s and early 2000s to 7\u201310% by the early 2020s in European and North American registries, although reported rates vary considerably by center, age group, and identification method. These bacteria also affect immunocompromised individuals outside the CF population. However, precise diagnosis and treatment of\n                    <jats:italic>Achromobacter<\/jats:italic>\n                    infections remain particularly challenging because of progressive difficulties: inaccurate species-level identification, limited clinical breakpoints for most species, and synergistic multidrug resistance mechanisms. This review synthesizes recent epidemiological data, outbreak investigations, and tentative epidemiological cutoff values (ECOFFs) for\n                    <jats:italic>A. xylosoxidans<\/jats:italic>\n                    established by EUCAST. We also present an integrated framework that links motility loss, biofilm formation, and resistance development to describe within-host adaptive evolution in the CF airway, and we highlight the role of biofilm-mediated tolerance and persister cells in chronic infection. By synthesizing multidimensional evidence, this review aims to provide a comprehensive reference framework for basic research and clinical management of\n                    <jats:italic>Achromobacter<\/jats:italic>\n                    , and to identify priority research directions, including the establishment of standardized identification procedures and the advancement of standardized clinical development of phage therapy.\n                  <\/jats:p>","DOI":"10.3389\/fmicb.2026.1954013","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:53:30Z","timestamp":1790247210000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["From an emerging pathogen to therapeutic challenges: advances in Achromobacter species, with a focus on A. xylosoxidans and cystic fibrosis"],"prefix":"10.3389","volume":"17","author":[{"given":"Yunfeng","family":"Xiang","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Chongqing University Three Gorges Hospital","place":["Wanzhou, Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoxue","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Chongqing University Three Gorges Hospital","place":["Wanzhou, Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Chongqing University Three Gorges Hospital","place":["Wanzhou, Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1055\/s-0034-1396929","article-title":"Stenotrophomonas, Achromobacter, and nonmelioid Burkholderia species: antimicrobial resistance and therapeutic strategies","volume":"36","author":"Abbott","year":"2015","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e0087025","DOI":"10.1128\/msphere.00870-25","article-title":"Achromobacter xylosoxidans isolates exhibit genome diversity, variable virulence, high levels of antibiotic resistance, and potential intrahost evolution","volume":"11","author":"Acharya","year":"2026","journal-title":"mSphere."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"7142","DOI":"10.1128\/AEM.02293-13","article-title":"Detection of Achromobacter xylosoxidans in hospital, domestic, and outdoor environmental samples and comparison with human clinical isolates","volume":"79","author":"Amoureux","year":"2013","journal-title":"Appl. Environ. Microbiol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e00290-17","DOI":"10.1128\/AAC.00290-17","article-title":"Role of AxyZ transcriptional regulator in overproduction of AxyXY-OprZ multidrug efflux system in Achromobacter species mutants selected by tobramycin","volume":"61","author":"Bador","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.3390\/jcm14072437","article-title":"The association of Achromobacter xylosoxidans airway infection with disease severity in cystic fibrosis","volume":"14","author":"Bar-On","year":"2025","journal-title":"J. Clin. Med."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e0072425","DOI":"10.1128\/jcm.00724-25","article-title":"Clinical and microbiologic features of Achromobacter species: a 10-year, multicenter experience","volume":"63","author":"Bayless","year":"2025","journal-title":"J. Clin. Microbiol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"23392","DOI":"10.1038\/s41598-025-06075-w","article-title":"Achromobacter xylosoxidans modulates Pseudomonas aeruginosa virulence through a complex multi-target competition","volume":"15","author":"Besse","year":"2025","journal-title":"Sci. Rep."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e1013067","DOI":"10.1371\/journal.ppat.1013067","article-title":"Achromobacter spp.: emerging pathogens in the cystic fibrosis lung","volume":"21","author":"Bhowmik","year":"2025","journal-title":"PLoS Pathog."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"116102","DOI":"10.1016\/j.diagmicrobio.2023.116102","article-title":"Clonal diversity, antimicrobial resistance, and genome features among nonfermenting gram-negative bacteria isolated from patients with cystic fibrosis in Russia","volume":"108","author":"Bocharova","year":"2024","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"762307","DOI":"10.3389\/fmicb.2022.762307","article-title":"Role of efflux in antibiotic resistance of Achromobacter xylosoxidans and Achromobacter insuavis isolates from patients with cystic fibrosis","volume":"13","author":"Chalhoub","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.3390\/v15081665","article-title":"Compounding Achromobacter phages for therapeutic applications","volume":"15","author":"Cobian Guemes","year":"2023","journal-title":"Viruses"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3389\/fcimb.2017.00224","article-title":"Uncovering differences in virulence markers associated with Achromobacter species of CF and non-CF origin","volume":"7","author":"Filipic","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e02911","DOI":"10.1128\/JCM.02911-20","article-title":"Transmission and antibiotic resistance of Achromobacter in cystic fibrosis","volume":"59","author":"Gabrielaite","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"000582","DOI":"10.1099\/mgen.0.000582","article-title":"Achromobacter spp. genetic adaptation in cystic fibrosis","volume":"7","author":"Gabrielaite","year":"2021","journal-title":"Microb Genom."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e0242221","DOI":"10.1128\/jcm.02422-21","article-title":"Distribution of Achromobacter species in 12 French cystic fibrosis centers in 2020 by a retrospective MALDI-TOF MS spectrum analysis","volume":"60","author":"Garrigos","year":"2022","journal-title":"J. Clin. Microbiol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"126.e1","DOI":"10.1016\/j.cmi.2020.03.031","article-title":"Development of a database for the rapid and accurate routine identification of Achromobacter species by matrix-assisted laser desorption\/ionization-time-of-flight mass spectrometry (MALDI-TOF MS)","volume":"27","author":"Garrigos","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e114356","DOI":"10.1371\/journal.pone.0114356","article-title":"Genotypic and phenotypic applications for the differentiation and species-level identification of Achromobacter for clinical diagnoses","volume":"9","author":"Gomila","year":"2014","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e01025","DOI":"10.1128\/AAC.01025-20","article-title":"Achromobacter infections and treatment options","volume":"64","author":"Isler","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e68484","DOI":"10.1371\/journal.pone.0068484","article-title":"Complete genome sequence of the cystic fibrosis pathogen Achromobacter xylosoxidans NH44784-1996 complies with important pathogenic phenotypes","volume":"8","author":"Jakobsen","year":"2013","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jcf.2022.11.001","article-title":"Clinical outcomes associated with Achromobacter species infection in people with cystic fibrosis","volume":"22","author":"Kerem","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e00523","DOI":"10.1128\/mSystems.00523-21","article-title":"Genomic and phenotypic evolution of Achromobacter xylosoxidans during chronic airway infections of patients with cystic fibrosis","volume":"6","author":"Khademi","year":"2021","journal-title":"mSystems"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e0008025","DOI":"10.1128\/spectrum.00080-25","article-title":"Highly carbapenem-resistant Achromobacter xylosoxidans harboring blaNDM-1 in Myanmar","volume":"13","author":"Kirikae","year":"2025","journal-title":"Microbiol. Spectrum"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3390\/v13010060","article-title":"A case of phage therapy against pandrug-resistant Achromobacter xylosoxidans in a 12-year-old lung-transplanted cystic fibrosis patient","volume":"13","author":"Lebeaux","year":"2021","journal-title":"Viruses"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"D801","DOI":"10.1093\/nar\/gkab902","article-title":"TYGS and LPSN: a database tandem for fast and reliable genome-based classification and nomenclature of prokaryotes","volume":"50","author":"Meier-Kolthoff","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"29298","DOI":"10.1038\/s41598-024-77246-4","article-title":"One year of ETI reduces lung bacterial colonization in adults with cystic fibrosis","volume":"14","author":"Mianowski","year":"2024","journal-title":"Sci. Rep."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"240068","DOI":"10.1183\/16000617.0068-2024","article-title":"Changing profile of bacterial infection and microbiome in cystic fibrosis: when to use antibiotics in the era of CFTR-modulator therapy","volume":"33","author":"Milczewska","year":"2024","journal-title":"Eur. Respir. Rev."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"105889","DOI":"10.1016\/j.mimet.2020.105889","article-title":"Expansion and improvement of MALDI-TOF MS databases for accurate identification of Achromobacter species","volume":"172","author":"Papalia","year":"2020","journal-title":"J. Microbiol. Methods"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ram.2019.03.004","article-title":"Diversity of Achromobacter species recovered from patients with cystic fibrosis, in Argentina","volume":"52","author":"Papalia","year":"2020","journal-title":"Rev. Argent. Microbiol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jgar.2024.11.012","article-title":"Genomic characterization of Achromobacter genogroup 20 and identification of a potential species-specific marker","volume":"40","author":"Papalia","year":"2025","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e0208322","DOI":"10.1128\/spectrum.02083-22","article-title":"The in vitro replication cycle of Achromobacter xylosoxidans and identification of virulence genes associated with cytotoxicity in macrophages","volume":"10","author":"Pickrum","year":"2022","journal-title":"Microbiol. Spectrum"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e0252724","DOI":"10.1128\/spectrum.02527-24","article-title":"Comparative phenotypic and genotypic antimicrobial susceptibility surveillance in Achromobacter spp. through whole genome sequencing","volume":"13","author":"Ray","year":"2025","journal-title":"Microbiol. Spectrum"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1099\/jmm.0.000763","article-title":"Effect of respiratory Achromobacter spp. infection on pulmonary function in patients with cystic fibrosis","volume":"67","author":"Recio","year":"2018","journal-title":"J. Med. Microbiol."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e0136790","DOI":"10.1371\/journal.pone.0136790","article-title":"Genetic adaptation of Achromobacter sp. during persistence in the lungs of cystic fibrosis patients","volume":"10","author":"Ridderberg","year":"2015","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1128\/JCM.00728-12","article-title":"Multilocus sequence analysis of isolates of Achromobacter from patients with cystic fibrosis reveals infecting species other than Achromobacter xylosoxidans","volume":"50","author":"Ridderberg","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"002051","DOI":"10.1099\/jmm.0.002051","article-title":"The cystic fibrosis pathogen Achromobacter xylosoxidans inhibits biofilm formation of Pseudomonas aeruginosa","volume":"74","author":"Sahl","year":"2025","journal-title":"J. Med. Microbiol."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e00195","DOI":"10.1128\/spectrum.00195-23","article-title":"Exoproducts of the most common Achromobacter species in cystic fibrosis evoke similar inflammatory responses in vitro","volume":"11","author":"Sahl","year":"2023","journal-title":"Microbiol. Spectrum"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1017\/ice.2022.52","article-title":"Outbreak and control of Achromobacter denitrificans at an academic hospital in Pretoria, South Africa","volume":"44","author":"Said","year":"2023","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3390\/ijms24087432","article-title":"In vivo inflammation caused by Achromobacter spp. cystic fibrosis clinical isolates exhibiting different pathogenic characteristics","volume":"24","author":"Sandri","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1128\/JCM.00814-12","article-title":"A multilocus sequence typing scheme implies population structure and reveals several putative novel Achromobacter species","volume":"50","author":"Spilker","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jcf.2012.10.002","article-title":"Identification and distribution of Achromobacter species in cystic fibrosis","volume":"12","author":"Spilker","year":"2013","journal-title":"J. Cyst. Fibros."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jhin.2024.02.002","article-title":"Achromobacter species (sp.) outbreak caused by hospital equipment containing contaminated water: risk factors for infection","volume":"146","author":"Tian","year":"2024","journal-title":"J. Hosp. Infect."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.bjid.2013.01.008","article-title":"Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcome","volume":"17","author":"Turel","year":"2013","journal-title":"Braz. J. Infect. Dis."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.syapm.2012.10.003","article-title":"Achromobacter animicus sp. nov., Achromobacter mucicolens sp. nov., Achromobacter pulmonis sp. nov. and Achromobacter spiritinus sp. nov., from human clinical samples","volume":"36","author":"Vandamme","year":"2013","journal-title":"Syst. Appl. Microbiol."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.syapm.2013.06.005","article-title":"Classification of Achromobacter genogroups 2, 5, 7 and 14 as Achromobacter insuavis sp. nov., Achromobacter aegrifaciens sp. nov., Achromobacter anxifer sp. nov. and Achromobacter dolens sp. nov., respectively","volume":"36","author":"Vandamme","year":"2013","journal-title":"Syst. Appl. Microbiol."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"07498","DOI":"10.1186\/s12887-026-07498-8","article-title":"Probable primary bloodstream infection caused by multidrug-resistant Achromobacter piechaudii in an apparently immunocompetent child: a case report","volume":"26","author":"Xiang","year":"2026","journal-title":"BMC Pediatr."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1348-0421.1998.tb02306.x","article-title":"Emendation of genus Achromobacter and Achromobacter xylosoxidans (Yabuuchi and Yano) and proposal of Achromobacter ruhlandii (packer and Vishniac) comb. nov., Achromobacter piechaudii (Kiredjian et al.) comb. nov., and Achromobacter xylosoxidans subsp. denitrificans (Ruger and tan) comb. nov","volume":"42","author":"Yabuuchi","year":"1998","journal-title":"Microbiol. Immunol."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1348-0421.1971.tb00607.x","article-title":"Achromobacter xylosoxidans n. sp. from human ear discharge","volume":"15","author":"Yabuuchi","year":"1971","journal-title":"JPN. J. Microbiol."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1099\/00207713-31-4-477","article-title":"Achromobacter gen. Nov. and Achromobacter xylosoxidans (ex Yabuuchi and Ohyama 1971) nom. Rev","volume":"31","author":"Yabuuchi","year":"1981","journal-title":"Int. J. Syst. Bacteriol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1954013\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:53:30Z","timestamp":1790247210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1954013\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":48,"alternative-id":["10.3389\/fmicb.2026.1954013"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1954013","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"article-number":"1954013"}}